Machine-learning model derived gene signature predictive of paclitaxel survival benefit in gastric cancer: results from the randomised phase III SAMIT trial.
Sundar R, Barr Kumarakulasinghe N, Huak Chan Y, Yoshida K, Yoshikawa T, Miyagi Y, Rino Y, Masuda M, Guan J, Sakamoto J, Tanaka S, Tan AL, Hoppe MM, Jeyasekharan AD, Ng CCY, De Simone M, Grabsch HI, Lee J, Oshima T, Tsuburaya A, Tan P.
Sundar R, et al. Among authors: huak chan y.
Gut. 2022 Apr;71(4):676-685. doi: 10.1136/gutjnl-2021-324060. Epub 2021 May 12.
Gut. 2022.
PMID: 33980610
Free PMC article.
Clinical Trial.